Asthma
COPD
Pulmonary
COPD: Page 26
Report highlights latest in COPD research and treatments
Emerging drugs, therapeutic assessments and company profiles are now available.
July 25, 2023
FDA clears new device for assisting in non-invasive ventilation
Elbow device helps eliminate the need for mask removal.
July 25, 2023
Collaboration looks to expand care for high-risk COPD patients
UC Davis Health and Propeller team to offer new tracking services for clinicians and patients.
July 17, 2023
Sponsored
Advocate for better air
Ascend Media
The ALA’s State of the Air report provides rankings and recommendations.
July 21, 2026
AI firm, digital health company partner on virtual COPD care
Partnership will provide healthcare options for patients in employer health plans.
July 17, 2023
FDA approval sought for emerging COPD maintenance treatment
Selective dual inhibitor could be the first novel mechanism for treating COPD in 10 years.
July 5, 2023
Pulse oximeter demand expected to rise in coming years
Technological advances, increased focus on continuous patient monitoring are driving factors of growth.
July 5, 2023
Sponsored
Advocate for better air
Ascend Media
The ALA’s State of the Air report provides rankings and recommendations.
July 21, 2026
Studies: Early intervention could reduce risk of future COPD exacerbation, CV events
June 12, 2023
Antiviral treatment for COPD reaches phase 2 development
June 12, 2023
Study suggests COPD tool could help pre-screen other acute respiratory infections
May 31, 2023
Sponsored
Advocate for better air
Ascend Media
The ALA’s State of the Air report provides rankings and recommendations.
July 21, 2026
Nuance administers dosing of first patient in ENHANCE
May 3, 2023
GSK to acquire BELLUS Health
April 21, 2023
TSOI identifies novel B regulatory cell mechanism for JadiCell universal donor adult stem cell
March 31, 2023
Previous Page
Page 26 of 27
Next Page
Most Popular
Hidden immune cell unlocks novel SCLC treatment approach
Long-term impact of pediatric TB patients
Primary care initiative tackles asthma rescue inhaler overuse
Mepolizumab reduces systemic corticosteroid exposure in COPD patients
The overlooked burden of comorbidities in severe asthma care
COPD treatment falls short in phase 2 proof-of-concept trial